Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a Missouri jury cleared the two infant formula makers of liability for a ...

Another group of cases bound for trial in 2025 are lawsuits alleging cow's milk-based infant formula produced by Mead Johnson ...

infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United ...

Creating a safe and calming space for a premature baby requires thoughtful preparation. Focus on soft lighting, a quiet ...

Abbott (ABT) announced that its board of directors has increased the company’s quarterly common dividend to 59c per share, an increase of 7.3%.

In a report released today, Suraj Kalia from Oppenheimer maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

In the closing of the recent trading day, Abbott (ABT) stood at $114.14, denoting a -1.18% change from the preceding trading day.

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Oppenheimer has recently initiated Abbott Laboratories (ABT) stock to Outperform rating, as announced on October 8, 2024, according to Finviz. Earlier, on September 19, 2024, Piper Sandler had ...

SEC Filings provided by EDGAR Online, Inc.